Measles Outbreak Driven by Nosocomial Transmission, Armenia, February–July 2023

https://wwwnc.cdc.gov/eid/article/32/2/25-0474_article

Autochthonous Rat Lungworm Angiostrongylus cantonensis Infections in Accidental and Definitive Hosts, San Diego, California, USA

https://wwwnc.cdc.gov/eid/article/32/2/25-1081_article

Multicenter Serologic Investigation of Influenza D Virus in Cats and Dogs, Europe, 2015–2024

https://wwwnc.cdc.gov/eid/article/32/2/25-1164_article

Avian Influenza A(H9N2) Virus Transmission across Chicken Production and Distribution Networks, Vietnam

https://wwwnc.cdc.gov/eid/article/32/2/25-1416_article

Correction: Vol. 32, No. 1

https://wwwnc.cdc.gov/eid/article/32/2/c1-3202_article

Pulmonary Complications in Fatal Yellow Fever, Brazil, 2017–2019

https://wwwnc.cdc.gov/eid/article/32/2/25-0530_article

Donor-Derived West Nile Virus Infection in Kidney Transplant Recipients, France, 2025

https://wwwnc.cdc.gov/eid/article/32/2/25-1569_article

Case of Legionella pneumophila Serogroup 1 Infection Linked to Water Flosser, France

https://wwwnc.cdc.gov/eid/article/32/2/25-1386_article

Airport Malaria Cluster in Certified Malaria-Free Country, Libya, 2024

https://wwwnc.cdc.gov/eid/article/32/2/25-1508_article

Neospora caninum Infection in Marine Mammals Stranding in Northeastern Pacific Ocean Region

https://wwwnc.cdc.gov/eid/article/32/2/25-1507_article

Review of the Performance of Laboratory-Based Molecular Diagnostics for Chlamydia trachomatis and Neisseria gonorrhoeae

https://academic.oup.com/cid/article/82/Supplement_1/S19/8496030?rss=1

Lymphocytic Choriomeningitis Virus Seroprevalence among Urban Pregnant Women and Newborns, Philadelphia, Pennsylvania, USA, 2021

https://wwwnc.cdc.gov/eid/article/32/3/25-0910_article

In the Literature

https://academic.oup.com/cid/article/82/2/ii/8497704?rss=1

State-of-the-Art Review: Chagas Disease—an Enduring Challenge

https://academic.oup.com/cid/article/82/2/187/8497697?rss=1

Intracranial Lesion in a Patient With Chronic Myeloid Leukemia

https://academic.oup.com/cid/article/82/2/354/8497682?rss=1

Bursting at the Seams

https://academic.oup.com/cid/article/82/2/337/8497666?rss=1

Interior of the Old Jersey Prison Ship in the Revolutionary War

https://academic.oup.com/cid/article/82/2/i/8497665?rss=1

[Profile] Reem Abu Shomar— championing water safety in Gaza
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00064-2/fulltext?rss=yes

As a Palestinian female scientist, Reem Abu Shomar experiences repeated trauma thinking of the war in Gaza. An expert in water safety and public health, Shomar spent more than two decades working in this sector in Gaza, and defended her PhD on water technology in September 2023, just weeks before her life and those of all she knew would be changed forever by the war. She is now based in Toronto, Canada, where she continues her public health and water safety research though collaboration with international partners.

[Correspondence] Precision diagnostics for MBLs: the true game changer in treating antimicrobial resistance – Authors' reply
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00009-5/fulltext?rss=yes

We thank Brenda A Warecki and colleagues for their thoughtful letter on our study on cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infection.1 They question whether the outcome of patients randomly assigned to cefiderocol might have been more favourable if the type of metallo-β-lactamase (MBL) was determined at the initiation of therapy using a rapid molecular diagnostic test, with the implication that patients infected with organisms harbouring NDM genes should have been excluded from the trial.

[Correspondence] Precision diagnostics for MBLs: the true game changer in treating antimicrobial resistance
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00008-3/fulltext?rss=yes

David L Paterson and colleagues recently evaluated cefiderocol versus standard-of-care therapy for hospital-acquired and health-care-associated bloodstream infections caused by Gram-negative bacilli.1 This was an international, open-label, parallel-group, randomised clinical trial. 250 patients received cefiderocol and 254 received standard-of-care treatment. Cefiderocol resulted in a non-inferior 14-day mortality compared with standard of care, even within the carbapenem-resistant subset. This interpretation places cefiderocol as effective treatment for Gram-negative bloodstream infections, regardless of the underlying carbapenemase mechanism.

[Comment] Peer review at The Lancet Infectious Diseases in 2025
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00079-4/fulltext?rss=yes

In this issue of The Lancet Infectious Diseases, the editorial team would like to thank all the researchers who peer reviewed for us in 2025. We express our gratitude to the 876 people from 82 countries who peer reviewed at least one article for us in the past year. We are particularly grateful to the peer reviewers who looked at more than one article and/or assessed several revisions. Without their expertise and constructive feedback, we would not be able to publish infectious disease research of the highest quality.